Atlas Trials

Spinal Muscular Atrophy Type 3

18 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Spinal Muscular Atrophy Type 3

RecordFirmDate
Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Treated With Nusinersen or Risdiplam (NCT05156320)Scholar Rock, Inc.2022-04-14
Spinal Cord Stimulation in Spinal Muscular Atrophy (NCT05430113)Marco Capogrosso2022-04-05
Pompe & Pain - Study to Assess Nociceptive Pain in Adult Patients With Pompe Disease (NCT05272969)LMU Klinikum2022-03-31
Musculoskeletal Nociceptive Pain in Participants With Neuromuscular Disorders (NCT04907162)LMU Klinikum2021-04-15
Wearable Technology to Assess Gait Function in SMA and DMD (NCT04193085)Columbia University2019-11-25
An Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular Atrophy (NCT03921528)Scholar Rock, Inc.2019-04-22
Long Term Safety of Amifampridine Phosphate in Spinal Muscular Atrophy 3 (NCT03819660)Catalyst Pharmaceuticals, Inc.2019-03-07
Spinraza in Adult Spinal Muscular Atrophy (NCT03709784)Washington University School of Medicine2018-08-16
Whole Body Vibration Therapy in Children With Spinal Muscular Atrophy (NCT03056144)The Hong Kong Polytechnic University2017-08-01
Oxidative Capacity and Exercise Tolerance in Ambulatory SMA (NCT02895789)Columbia University2016-11-01
Safety and Efficacy Study of Pyridostigmine on Patients With Spinal Muscular Atrophy Type 3 (NCT02227823)Centre Hospitalier Régional de la Citadelle2014-07-01

Track Spinal Muscular Atrophy Type 3 automatically

Every clearance here is in the API, with alerts when new ones post.